A detailed history of Comerica Bank transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Comerica Bank holds 65,227 shares of BMRN stock, worth $4.14 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
65,227
Previous 73,218 10.91%
Holding current value
$4.14 Million
Previous $6.03 Million 23.95%
% of portfolio
0.02%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$69.02 - $93.84 $551,538 - $749,875
-7,991 Reduced 10.91%
65,227 $4.58 Million
Q2 2024

Aug 15, 2024

BUY
$74.43 - $92.22 $4.92 Million - $6.1 Million
66,161 Added 937.52%
73,218 $6.03 Million
Q1 2024

May 15, 2024

SELL
$83.81 - $99.0 $24,807 - $29,304
-296 Reduced 4.03%
7,057 $616,000
Q4 2023

Feb 14, 2024

BUY
$76.22 - $98.51 $155,260 - $200,664
2,037 Added 38.32%
7,353 $708,000
Q3 2023

Nov 21, 2023

SELL
$85.07 - $94.48 $2.5 Million - $2.77 Million
-29,334 Reduced 84.66%
5,316 $470,000
Q2 2023

Aug 22, 2023

BUY
$86.68 - $100.3 $2.73 Million - $3.16 Million
31,528 Added 1009.87%
34,650 $63,000
Q4 2022

Jan 26, 2023

BUY
$80.93 - $108.63 $24,683 - $33,132
305 Added 10.83%
3,122 $0
Q3 2022

Oct 28, 2022

BUY
$82.16 - $96.94 $30,481 - $35,964
371 Added 15.17%
2,817 $253,000
Q2 2022

Aug 02, 2022

SELL
$71.48 - $86.85 $233,096 - $283,217
-3,261 Reduced 57.14%
2,446 $211,000
Q1 2022

Apr 27, 2022

SELL
$74.28 - $92.69 $388,113 - $484,305
-5,225 Reduced 47.8%
5,707 $440,000
Q4 2021

Feb 18, 2022

SELL
$71.72 - $91.47 $645,336 - $823,047
-8,998 Reduced 45.15%
10,932 $965,000
Q3 2021

Nov 22, 2021

SELL
$74.77 - $85.47 $347,381 - $397,093
-4,646 Reduced 18.9%
19,930 $1.54 Million
Q2 2021

Aug 26, 2021

SELL
$75.51 - $84.79 $138,409 - $155,420
-1,833 Reduced 6.94%
24,576 $2.05 Million
Q1 2021

Apr 28, 2021

SELL
$74.73 - $90.69 $43,941 - $53,325
-588 Reduced 2.18%
26,409 $1.99 Million
Q4 2020

Jan 28, 2021

BUY
$72.61 - $90.2 $206,067 - $255,987
2,838 Added 11.75%
26,997 $2.37 Million
Q3 2020

Oct 30, 2020

SELL
$71.87 - $131.03 $13,799 - $25,157
-192 Reduced 0.79%
24,159 $1.84 Million
Q2 2020

Jul 31, 2020

SELL
$79.55 - $124.22 $1,193 - $1,863
-15 Reduced 0.06%
24,351 $3 Million
Q1 2020

May 01, 2020

BUY
$71.37 - $96.85 $724,120 - $982,640
10,146 Added 71.35%
24,366 $2.06 Million
Q4 2019

Feb 07, 2020

BUY
$64.27 - $86.37 $44,603 - $59,940
694 Added 5.13%
14,220 $1.2 Million
Q3 2019

Oct 31, 2019

BUY
$67.4 - $85.11 $3,707 - $4,681
55 Added 0.41%
13,526 $911,000
Q2 2019

Aug 02, 2019

BUY
$80.35 - $93.9 $64,038 - $74,838
797 Added 6.29%
13,471 $0
Q1 2019

May 02, 2019

BUY
$84.2 - $98.62 $220,098 - $257,792
2,614 Added 25.98%
12,674 $0
Q4 2018

Feb 06, 2019

SELL
$80.14 - $106.07 $2,885 - $3,818
-36 Reduced 0.36%
10,060 $948,000
Q3 2018

Nov 01, 2018

BUY
$93.92 - $105.72 $53,064 - $59,731
565 Added 5.93%
10,096 $1.01 Million
Q2 2018

Aug 01, 2018

BUY
$76.01 - $99.03 $189,188 - $246,485
2,489 Added 35.35%
9,531 $991,000
Q1 2018

May 01, 2018

SELL
$77.67 - $92.63 $11,029 - $13,153
-142 Reduced 1.98%
7,042 $589,000
Q4 2017

Feb 02, 2018

SELL
$80.76 - $95.13 $11,064 - $13,032
-137 Reduced 1.87%
7,184 $656,000
Q3 2017

Nov 06, 2017

BUY
$80.6 - $94.95 $590,072 - $695,128
7,321
7,321 $600,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.